Total Payments
$175,564
2024 Payments
$403.26
Companies
27
Transactions
379
Medicare Patients
17,604
Medicare Billing
$1.1M
Payment Breakdown by Category
Other$158,600 (90.3%)
Food & Beverage$9,514 (5.4%)
Travel$7,358 (4.2%)
Education$92.28 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $158,600 | 50 | 90.3% |
| Food and Beverage | $9,514 | 275 | 5.4% |
| Travel and Lodging | $7,358 | 52 | 4.2% |
| Education | $92.28 | 2 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $172,312 | 253 | $0 (2024) |
| Journey Medical Corporation | $1,220 | 15 | $0 (2024) |
| Janssen Biotech, Inc. | $274.80 | 18 | $0 (2024) |
| Lilly USA, LLC | $266.46 | 15 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $206.19 | 11 | $0 (2020) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $201.76 | 12 | $0 (2021) |
| Regeneron Healthcare Solutions, Inc. | $187.54 | 9 | $0 (2021) |
| MAYNE PHARMA INC. | $152.44 | 8 | $0 (2020) |
| PruGen, Inc. Pharmaceuticals | $103.36 | 2 | $0 (2019) |
| UCB, Inc. | $102.50 | 6 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $403.26 | 16 | Journey Medical Corporation ($136.85) |
| 2023 | $365.82 | 6 | Journey Medical Corporation ($305.80) |
| 2022 | $27,571 | 39 | ABBVIE INC. ($27,394) |
| 2021 | $27,946 | 65 | AbbVie Inc. ($27,323) |
| 2020 | $9,509 | 29 | AbbVie Inc. ($9,205) |
| 2019 | $67,547 | 103 | AbbVie, Inc. ($66,768) |
| 2018 | $22,054 | 63 | AbbVie, Inc. ($21,603) |
| 2017 | $20,169 | 58 | AbbVie, Inc. ($19,913) |
All Payment Transactions
379 individual payment records from CMS Open Payments — Page 1 of 16
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $19.59 | General |
| Category: Immunology | ||||||
| 11/06/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | SPEVIGO (Drug) | Food and Beverage | In-kind items and services | $20.69 | General |
| Category: IMMUNOLOGY | ||||||
| 10/23/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $15.06 | General |
| Category: IMMUNOLOGY | ||||||
| 10/09/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $16.90 | General |
| Category: IMMUNOLOGY | ||||||
| 09/17/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $14.79 | General |
| Category: Immunology | ||||||
| 08/27/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $18.46 | General |
| Category: IMMUNOLOGY | ||||||
| 08/09/2024 | Journey Medical Corporation | — | Food and Beverage | In-kind items and services | $123.22 | General |
| 08/09/2024 | Journey Medical Corporation | — | Food and Beverage | In-kind items and services | $13.63 | General |
| 07/16/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $13.86 | General |
| Category: IMMUNOLOGY | ||||||
| 06/12/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $22.02 | General |
| Category: IMMUNOLOGY | ||||||
| 06/05/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $15.70 | General |
| Category: Immunology | ||||||
| 05/07/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $21.14 | General |
| Category: IMMUNOLOGY | ||||||
| 03/26/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $23.40 | General |
| Category: Immunology | ||||||
| 03/21/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $16.76 | General |
| Category: Immunology | ||||||
| 03/19/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $29.35 | General |
| Category: Inflammation | ||||||
| 03/11/2024 | Lilly USA, LLC | TALTZ (Drug) | Food and Beverage | In-kind items and services | $18.69 | General |
| Category: Immunology | ||||||
| 08/24/2023 | Lilly USA, LLC | TALTZ (Drug) | Food and Beverage | In-kind items and services | $13.05 | General |
| Category: Immunology | ||||||
| 07/10/2023 | Lilly USA, LLC | — | Food and Beverage | In-kind items and services | $17.90 | General |
| 05/31/2023 | Journey Medical Corporation | — | Food and Beverage | In-kind items and services | $92.40 | General |
| 04/19/2023 | Journey Medical Corporation | — | Food and Beverage | In-kind items and services | $107.40 | General |
| 04/05/2023 | MEDLINE INDUSTRIES LP | — | Food and Beverage | In-kind items and services | $29.07 | General |
| 03/17/2023 | Journey Medical Corporation | — | Food and Beverage | In-kind items and services | $106.00 | General |
| 10/21/2022 | ABBVIE INC. | HUMIRA (Biological) | Travel and Lodging | In-kind items and services | $130.00 | General |
| Category: IMMUNOLOGY | ||||||
| 10/19/2022 | ABBVIE INC. | HUMIRA (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,375.00 | General |
| Category: IMMUNOLOGY | ||||||
| 10/14/2022 | ABBVIE INC. | HUMIRA (Biological) | Food and Beverage | In-kind items and services | $44.22 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 17 | 3,938 | 7,789 | $740,628 | $241,803 |
| 2022 | 17 | 4,318 | 8,740 | $813,033 | $270,806 |
| 2021 | 19 | 4,602 | 8,864 | $886,825 | $314,528 |
| 2020 | 21 | 4,746 | 8,413 | $1.3M | $321,581 |
Total Patients
17,604
Total Services
33,806
Medicare Billing
$1.1M
Procedure Codes
74
All Medicare Procedures & Services
74 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Office | 2023 | 1,395 | 2,105 | $265,707 | $93,400 | 35.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 475 | 639 | $111,135 | $34,133 | 30.7% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 514 | 693 | $85,100 | $21,472 | 25.2% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 259 | 308 | $63,990 | $20,921 | 32.7% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 109 | 146 | $44,831 | $16,339 | 36.4% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 460 | 3,082 | $36,306 | $13,280 | 36.6% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 171 | 191 | $36,359 | $10,569 | 29.1% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 207 | 244 | $25,796 | $8,417 | 32.6% |
| 17282 | Destruction of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 1.1-2.0 cm | Office | 2023 | 34 | 38 | $14,719 | $5,269 | 35.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 54 | 54 | $11,589 | $3,010 | 26.0% |
| 17272 | Destruction of cancer skin growth of scalp, neck, hands, feet, or genitals, 1.1-2.0 cm | Office | 2023 | 19 | 23 | $8,123 | $2,773 | 34.1% |
| 88304 | Pathology examination of tissue using a microscope, moderately low complexity | Office | 2023 | 90 | 97 | $7,263 | $2,528 | 34.8% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2023 | 21 | 21 | $6,990 | $2,307 | 33.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 28 | 31 | $7,672 | $2,205 | 28.7% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 49 | 64 | $6,241 | $2,163 | 34.7% |
| 88312 | Special stained specimen slides to identify organisms including interpretation and report | Office | 2023 | 24 | 24 | $4,796 | $1,718 | 35.8% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2023 | 29 | 29 | $4,011 | $1,299 | 32.4% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Office | 2022 | 1,848 | 2,784 | $352,328 | $126,201 | 35.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 486 | 662 | $115,135 | $35,038 | 30.4% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2022 | 143 | 224 | $68,781 | $21,963 | 31.9% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 518 | 661 | $81,171 | $21,912 | 27.0% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 210 | 246 | $51,109 | $17,925 | 35.1% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 500 | 3,498 | $41,206 | $15,175 | 36.8% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 151 | 158 | $30,077 | $8,843 | 29.4% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 127 | 140 | $14,801 | $4,751 | 32.1% |
About Dr. Jeffrey Jackson, M.D
Dr. Jeffrey Jackson, M.D is a Dermatopathology healthcare provider based in Elkins, West Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/27/2006. The National Provider Identifier (NPI) number assigned to this provider is 1780611590.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jeffrey Jackson, M.D has received a total of $175,564 in payments from pharmaceutical and medical device companies, with $403.26 received in 2024. These payments were reported across 379 transactions from 27 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($158,600).
As a Medicare-enrolled provider, Jackson has provided services to 17,604 Medicare beneficiaries, totaling 33,806 services with total Medicare billing of $1.1M. Data is available for 4 years (2020–2023), covering 74 distinct procedure/service records.
Ad
Practice Information
- Specialty Dermatopathology
- Other Specialties Dermatology
- Location Elkins, WV
- Active Since 06/27/2006
- Last Updated 01/23/2015
- Taxonomy Code 207ND0900X
- Entity Type Individual
- NPI Number 1780611590
Products in Payments
- Humira (Biological) $61,808
- Skyrizi (Biological) $41,530
- SKYRIZI (Biological) $36,468
- HUMIRA (Biological) $24,871
- RINVOQ (Biological) $2,672
- TALTZ (Drug) $248.56
- COSENTYX (Biological) $184.75
- DORYX (Drug) $152.44
- DUPIXENT DUPILUMAB INJECTION (Biological) $133.00
- TREMFYA (Drug) $117.92
- Tremfya (Drug) $106.44
- Exelderm (Drug) $84.39
- EUCRISA (Drug) $77.34
- Absorica (Drug) $73.17
- Cimzia (Drug) $67.21
- DUPIXENT (Biological) $54.54
- REMICADE (Biological) $50.44
- Otezla (Drug) $47.73
- ILUMYA (Biological) $40.96
- Sotyktu (Drug) $38.19
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.